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Purpose: To investigate the effects of daily oral L-leucine ingestion on strength, 
bone mineral-free lean tissue mass (LTM) and fat mass (FM) of free living 
humans during a 12-week resistance-training program. Methods: Twenty six 
initially untrained men (n = 13 per group) ingested either 4 gd-1 of L-Leucine 
(leucine group: age 28.5 ± 8.2 y, body mass index 24.9 ± 4.2 kgm-2) or a 
corresponding amount of lactose (placebo group: age 28.2 ± 7.3 y, body mass 
index 24.9 ± 4.2 kgm-2). All participants trained under supervision twice per 
week following a prescribed resistance training program using eight standard 
exercise machines. Testing took place at baseline and at the end of the 
supplementation period. Strength on each exercise was assessed by five repetition 
maximum (5-RM), and body composition was assessed by dual energy X-ray 
absorptiometry (DXA). Results: The leucine group demonstrated significantly 
higher gains in total 5-RM strength (sum of 5-RM in eight exercises) and 5-RM 
strength in five out of the eight exercises (P < 0.05). The percentage total 5-RM 
strength gains were 40.8% (± 7.8) and 31.0% (± 4.6) for the leucine and placebo 
groups respectively. Significant differences did not exist between groups in either 
total percentage LTM gains or total percentage FM losses (LTM: 2.9% ± 2.5 
versus 2.0% ± 2.1, FM: 1.6% ± 15.6 versus 1.1% ± 7.6). Conclusion: These 
results suggest that 4 gd-1 of L-leucine supplementation may be used as a 
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nutritional supplement to enhance strength performance during a 12-week 
resistance training program of initially untrained male participants.  
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Introduction 
 
Leucine is one of the essential amino acids that belongs to the group of branched-
chain amino acids (BCAA) and may play a specific and pertinent role in the 
regulation of protein turnover. It has been demonstrated clearly that leucine may 
act as nutrient signal to stimulate protein synthesis in animal studies,1, 2 thus 
having the potential to enhance anabolism and act as an ergogenic aid. In humans, 
intravenous infusion of leucine may decrease protein degradation at rest,3 whilst 
oral ingestion of leucine and essential amino acids may increase muscle protein 
synthesis at rest in both young and elderly individuals.4 Addition of leucine to a 
carbohydrate/protein supplement post-exercise has been shown to elicit greater 
responses in the rate of muscle protein synthesis in healthy male subjects than a 
carbohydrate and a carbohydrate/protein supplement following a resistance 
exercise bout.5 However, others have suggested that co-ingestion of leucine and 
whey protein before exercise does not result in a greater anabolic response than 
whey protein alone.6 In terms of sports performance, leucine supplementation has 
been shown to increase time to exhaustion and the upper body power of rowers 
during six weeks of supplementation7 to a greater extent than a placebo condition, 
whilst co-ingestion of protein and leucine during eight weeks of resistance 
training has shown to elicit further gains in one repetition maximum strength (1-
RM) than a placebo (carbohydrate) and a control condition.8  
 
Bearing in mind the results of the aforementioned studies, it is probable that 
supplementation of leucine during resistance exercise training may be beneficial 
in terms of strength gains and muscle growth. Surprisingly, the capacity of orally 
ingested leucine alone to enhance strength and muscle mass in humans, whilst 
following an identical prescribed resistance-training program has not been tested. 
It has also been suggested that the recommended dietary intake of leucine of 14 
mg·kg-1·BW·d-1 (where BW = body weight) is inadequate in individuals who are 
physically active.9, 10 At a protein intake of 1.26 g·kg-1·BW·d-1, the serum 
concentrations of amino acids are lowered considerably during training of 
athletes.9 Leucine supplementation of 50 mg·kg-1·BW·d-1 appears to prevent the 
decrease in the serum leucine concentration during training.9 Therefore, a dose of 
similar magnitude was utilised in the present study. 
 
The potential of leucine to stimulate primarily protein synthesis provides the basis 
and justification to ingest leucine during resistance exercise training in order to 
enhance muscle growth and ultimately improve strength and personal 
performance. An increase in muscle size is generally accompanied by an increase 
in strength.11 Strength gains may lead to improved performance in athletic 
disciplines and everyday life.12 Gains in lean mass and losses in fat mass may 
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result in physiological adaptations that decrease the risk of diseases such as 
cardiovascular disease.13 Therefore, the main aim of the present study is to 
investigate the capacity of 4 gd-1 oral ingestion of leucine alone to enhance 
strength, lean mass and decrease fat mass during a 12-week resistance-training 
program of initially untrained male participants. Our expectation was that 
supplementation with leucine would lead to further gains in muscle growth and 
consequently strength when compared to a placebo condition. 
 
Methods 
Participants 
Forty healthy males were recruited in stages. Participants who failed to follow the 
resistance training program and did not comply with our participation 
requirements described below were removed from the study. Thus, the required 
number of 13 participants per group (determined by power calculation using 
Machin’s software version 2) was met. The volunteers were assigned to a placebo 
group (P)  (28.2 ± 7.3 y; 1.77 ± 0.10 m; 78.4 ± 16.8 kg; BMI 24.9 ± 4.2 kgm-2) 
and a leucine supplemented group (L) (28.5 ± 8.2 y; 1.76 ± 0.05 m; 77.6 ± 7.9 kg; 
BMI 24.6 ± 3.2 kgm-2). Attempts were made to match pairs of participants as 
closely as possible on age and BMI. Medical history and lifestyle evaluation 
questionnaires were collected before the assignment of the participants to one of 
the two conditions. The participants had never taken part in any structured 
resistance training program or any other type of exercise training program in the 
past. Volunteers who had participated in any type of training the 6 months 
preceding the baseline measurements were also excluded. None of the participants 
had diabetes, high blood pressure, or symptomatic disease, including 
cardiovascular disease. All participants were free from medication and were not 
taking any other nutritional supplements during or before the intervention. The 
study was approved by the Leeds West Research Ethics Committee. All 
participants received information sheets and had the opportunity to ask questions 
about the potential benefits, risks and design of the study before informed consent 
was obtained.  
 
Experimental Design and Strength Training Protocol 
The design of the study was placebo-controlled and double blind. The participants 
agreed to take part exclusively in the assigned resistance training program. Both 
groups received identical prescribed resistance training over a period of 12 weeks. 
The participants were advised to maintain the same lifestyle and physical activity 
levels prior to the commencement of the experimental period. The standard 
machines used during the strength assessment and strength training sessions were 
as follows: Leg Press, Bench Press, Chest Cross, Pullover, Overhead Press, 
Preacher Curls, Triceps Press (All Nautilus, USA) and Prone Leg Curl (1-800-
Nautilus Nitro, USA). All sessions took place in a University gym. The 
participants trained twice per week (with 2-3 rest days between sessions). 
According to the position stand of the American College of Sports Medicine 
(ACSM) the initial resistance for novice subjects should be in the range of 8-12 
repetition maximum (RM) strength, and the training frequency 2-3 days per 
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week.14 The duration of the training program was set at 12 weeks as muscle 
growth is more likely to become evident after 6-7 weeks of resistance training.15 
 
Five repetition maximum (5-RM) testing took place at baseline, at weeks 4, 8 and 
12 of the experimental period. The participants warmed-up using a cycle 
ergometer (Startrac Pro, USA) for a period of 5-min followed by 5-min of 
dynamic arm and leg movements combined with gentle stretching of arms and 
legs. A 5-min rest was given between each trial to allow for adequate recovery. 5-
RM was employed for assessment of strength in order to minimise the risk of 
injury because all subjects were untrained at baseline, and to determine rather than 
estimate the training loads during the strength workouts.16 Multiple RM testing 
between 3-RM to 6-RM has also been shown to be a valid index of  assessment of 
strength.16 In addition to measuring 5-RM strength in all 8 exercises, total 5-RM 
was determined by the sum of 5-RM strength on each individual exercise. One 
week before the first 5-RM testing all participants were familiarised with the 
training equipment using light resistance. 
 
The training protocol combined two different types of workouts shown to increase 
strength and muscle size.17 The hypertrophy workout involved 3 sets of 10 
repetitions with 1-min rest between sets; the training loads were adjusted in order 
to allow the participants to perform just 10 repetitions during the last set. During 
the strength workouts the resistance used was the 5-RM achieved during the 
previous assessment; participants in this case performed 4 x 5-RM with 3-min 
recovery between sets. If for any reason participants were unable to complete 5 
repetitions during their final set, resistance was adjusted in a subsequent session to 
allow them to perform 5 repetitions during the final set.  
 
Assessment of Body composition 
Total and regional (arms, legs and trunk) body composition was assessed at 
baseline and at the end of the supplementation period by dual energy X-ray 
absorptiometry (DXA). A DXA scanner (Prodigy Lunar, GE Medical Systems, 
serial No: 10395, USA) was used for the assessment of bone mineral-free lean 
tissue mass (LTM) and fat mass (FM). The testing took place in the Centre for 
Bone and Body Composition Research, Leeds University. DXA has been 
validated against other methods and has shown little bias based on age, fat 
distribution, activity levels, gender or race, whilst at the same time is a more 
sensitive method for assessing small and regional changes in body composition.18, 
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Diet and Supplements 
The participants were asked to maintain their habitual diet throughout the 
experimental period and were asked to keep diet diaries for a period of 4 days at 
the midpoint of the study to include two training, one weekend and one week non-
training days. The parameters assessed for dietary analysis were: carbohydrate, 
protein, fat and alcohol intake. The CompEat program 5.7 (CompEat version 5, 
Nutrition systems, Grantham, UK) was used for the analysis of diary records. The
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resting energy expenditure (REE) was calculated using the Harris-Benedict 
equation20 and the total energy requirements were estimated by multiplying REE 
with a factor of 1.35.21  
 
Supplementation was continuous for the duration of the study. On non-training 
days participants were asked to take the supplements in 3 equal doses during the 
day (morning, midday, evening). On training days, the supplements were ingested 
immediately following exercise. The doses were 4 gd-1 (approximately 50 mg·kg-
1·BW·d-1) for leucine (L-Leucine white crystalline powder, Ajinomoto Co. Inc., 
Tokyo, Japan) and a corresponding amount of lactose (99% lactose monohydrate, 
Dairy Crest Ingredients, Surrey, UK). The composition of the placebo was not 
revealed to the participants. The leucine dose (4 gd-1) resulted from the average 
weight for British men of 77.2 kg (Allied Dunbar National Fitness Survey);22 50 
mg·kg-1·BW·d-1 seems to be an adequate quantity to prevent a decrease in serum 
leucine concentration during intensive training of athletes.9 There was good 
reason to believe that post-exercise supplementation in addition to regular 
supplementation through the day would be more likely to enhance any anabolic 
effect of leucine than daily supplementation alone. This is because previous 
research has shown that ingestion of protein and amino acid mixtures immediately 
after (ideally within the first hour) exercise can create a more anabolic 
environment conducive to muscle hypertrophy.23 Continuity of supplementation 
was also of significant importance as protein turnover may remain elevated for up 
to 48-h following the end of exercise.24 We expected that ingestion of leucine at 
different time points during non-exercising days (in combination with ingestion of 
nutrients through their normal diet) would create a sustained positive or a more 
positive protein balance conducive to muscle hypertrophy throughout the day.  
 
The volume of each drink was approximately 150 mL and consisted of 4 parts 
water, one part squash (Kia-Ora, Coca Cola Enterprises Ltd) and the daily 
supplement doses; the energy value excluding the supplements was approximately 
16 kcal (11 kcal·100 mL-1). The squash was added in the drinks in an attempt to 
disguise the taste of the supplements and in particular the bitterness of leucine. 
The energy value of 4 gd-1 of lactose was 16 kcal (400 kcal·100 g-1), whilst the 
energy value of 4 gd-1 of leucine was 24.8 kcal (6.2 kcal·g-1). Powders were 
dispensed in plastic food bags that were sealed, placed in opaque envelopes, 
which were labelled as A, or B and then distributed to the participants. The 
participants were instructed to shake well the mix in the supplied beakers (black 
colour). As a result there were no residues of leucine or lactose left in the beakers. 
Furthermore, as the experimental groups were discreet groups, neither the 
participants in the leucine group nor the participants in the placebo group knew 
what the drink tasted like in the opposite group. 
 
Ratings of Perceived Exertion and Seven Day Physical Activity Recall 
Ratings of perceived exertion (RPE) were recorded at the end of each exercise 
within each training bout to compute session RPE (Average of RPE in 8 
exercises). The 6-20 Borg scale has been used in resistance training studies to 
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monitor exercise intensity25 and has been found to be a very useful tool to 
distinguish between different training intensities. In addition to RPE, a seven-day 
physical activity recall (7-day PAR) interview took place at the end of the 
supplementation period. The purpose of the 7-day PAR, a reliable index in 
assessing activity levels26 was to explore the activity levels of the two groups 
towards the end of the experimental period.  
 
Blood Samples 
Blood samples were drawn by venepuncture after a minimum of 10-h  overnight 
fast at the beginning and at the end of the supplementation period to assess liver 
function (liver enzymes, bilirubin and albumin) and blood profile (standard full 
blood count). Subjects remained seated in a reclined position for 5-min before the 
sample was drawn from one of the brachial, medial cubital or radial veins. The 
samples were drawn in succession into a Gold 3.5-mL (13 x 75 mm) BD SST II 
Vacutainer (BD Vacutainer Systems Preanalytical Solutions, UK) and a purple 
EDTA 4-mL Vacuette (Vacuette, Greiner Bio-One, Austria). The samples were 
transferred to the department of Clinical Biochemistry and Immunology, Leeds 
General Infirmary) for subsequent analysis. No other tests were conducted on 
blood sampling days. 
 
 
 
Statistical analysis 
Data are presented as means (± standard deviations). Independent t-test were 
employed to test for significant differences between groups in percentage strength 
and percentage LTM and FM differences (the difference between the absolute 
values expressed as percentage of the baseline value). In addition, effect sizes 
were computed by using the method of Cohen. Independent t-test were also 
employed for analysing 7-Day PAR data and mean differences of blood data 
(post-exercise absolute values minus baseline absolute values). Comparison of 
RPE data (average for each training session) were made using a 2-Way ANOVA 
(condition*training sessions) with repeated measures across the training period for 
both the hypertrophy and strength training workouts. The alpha level of statistical 
significance was set at P < 0.05. Data were analysed using the statistical package 
for the social sciences, version 16.0 (SPSS, Inc., Chicago, USA). 
 
Results 
Strength variables  
Table 1 provides the descriptive statistics at baseline and end of the 
supplementation period. The percentage gains from baseline until the end of the 
experimental period in 5-RM strength for both groups ranged between 19% and 
60% with a gain of approximately 30-40% in the majority of exercises (Table 1). 
On average the percentage 5-RM strength gains for the L group were 
approximately 10% higher than the P group. Statistical analysis on the mean 
percentage gains across the 12-week experimental period showed that the L group 
had significantly greater percentage mean gains than the P group in 5 out of 8 
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exercises and total strength (P < 0.05) (Table 1). The statistical analysis showed 
significant differences between groups for leg press (t24 = -2.79; P = 0.010), bench 
press (t24 = -2.45; P = 0.02), pullover (t24 = -2.33; P = 0.03), preacher curls (t24 = -
3.17; P = 0.004), triceps press (t24 = -3.47; P = 0.002) and total strength (t24 = -
4.06; P < 0.001). No significant differences between conditions were observed for 
leg curls (P = 0.19), chest cross (P = 0.08) and overhead press (P = 0.35). 
 
Body Composition 
Table 2 reports the body composition variables at baseline and week 12. The 
mean gains in total bone mineral-free lean tissue mass (LTM) and losses in total 
fat mass (FM) were 1.08 kg (±1.1), 1.53 kg (±1.3) and 0.41 kg (±1.4), 0.93 kg 
(±3.0) on average for P and L groups respectively. Independent t-test showed that 
these percentage changes were not significantly different between groups (LTM: 
t24 = -0.94; P = 0.36 and FM: t24 = 0.10; P = 0.92). Similarly, significant 
differences did not exist between groups in LTM or FM of arm, leg and trunk 
regions (Table 2).   
 
Dietary intake 
The daily percentage contribution of different nutrients and alcohol to total energy 
as well as the total energy intakes were similar for both groups (Table 3). One 
participant from the P and 2 participants from the L group failed to submit their 
diet diaries. The P group met 98.2% (±24.6) and the L group 89.8% (±18.2) of the 
estimated energy requirements. The dietary grams of protein per kilogram of body 
weight were 0.88 g (±0.28) and 0.90 g (±0.15) for P and L groups respectively. 
There were no significant differences between the 2 groups in either absolute or 
percentage terms. 
8 
Table 1: Mean strength expressed as five repetition maximum strength (5-RM) at baseline and at the end of the supplementation period in 8 
resistance exercises and total strength. 
 
Exercises Placebo (n = 13) Leucine (n = 13) Effect Size 
 Baseline Week 12 % Mean Gain Baseline Week 12 % Mean Gain 
Leg Press (kg) 171.1 ± 28.4 216.9 ± 35.1 27.0 ± 7.8 169.7 ± 26.3 232.3 ± 33.3 37.4 ± 11.0** 0.5 
Bench Press (kg) 71.3 ± 12.0 93.6 ± 12.9 31.9 ± 8.7 71.5 ± 19.7 99.7 ± 22.4 41.5 ± 10.9* 0.4 
Leg Curls (kg) 58.1 ± 12.4 68.3 ± 12.0 18.6 ± 7.5 58.2 ± 12.7 71.0 ± 12.5 23.0 ± 9.1 0.3 
Chest Cross (kg) 56.5 ± 12.8 82.6 ± 14.4 48.2 ± 10.7 56.0 ± 17.4 87.2 ± 20.4 59.8 ± 19.9 0.3 
Pullover (kg) 71.1 ± 14.3 89.1 ± 15.4 26.3 ± 7.7 68.6 ± 15.7 92.3 ± 19.3 35.4 ± 11.9* 0.4 
Overhead Press (kg) 36.1 ± 6.9 53.0 ± 8.8 48.0 ± 14.7 39.3 ± 12.9 58.9 ± 14.8 53.8 ± 16.0 0.2 
Preacher Curls (kg) 47.3 ±9.0 60.4 ± 9.1 29.0 ± 9.0 46.6 ± 8.8 64.4 ± 9.9 39 ± 6.9** 0.5 
Triceps press (kg) 75.3 ± 11.1 102.6 ± 12.4 36.9 ± 7.2 76.0 ± 17.1 113.6 ± 18.1 51.7 ± 13.6** 0.6 
Total Strength (kg) 587.1 ± 89.6 766.6 ± 103.7 31.0 ± 4.6 586.0 ± 115.3 819.5 ± 129.3 40.8 ± 7.4** 0.6 
* Denotes significant difference in percentage gain between the placebo and Leucine condition (* P < 0.05; **P < 0.01). 
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Table 2: Bone mineral-free lean tissue mass (LTM), fat mass (FM) and soft tissue mass (STM = LTM + FM) by DXA at baseline and at the end 
of the experimental period. 
 
Body composition Variables Placebo (n=13) Leucine (n=13) Effect Size 
 Baseline Week 12 % Change Baseline Week 12 % Change 
Arm  FM (kg) 1.6 ±1.0 1.5± 1.0 -3.1 ± 12.7 1.8 ± 0.8 1.7 ± 0.6 -3.8 ± 12.2 0.02 
Leg FM  (kg)  6.8 ± 3.0 6.5 ± 2.8 -4.4 ±  7.1 7.1 ± 1.7 6.9 ± 1.3 -1.1 ± 13.8 0.1 
Trunk  FM (kg) 11.3 ± 6.2 11.2 ± 5.7 -1.3 ±  8.6 12.1 ± 4.9 11.5 ± 4.0 -1.5 ± 18.5 0.006 
Arm LTM (kg) 6.6 ± 0.9 7.0 ± 0.9 6.1 ±  5.6 6.5 ± 0.9 7.0 ± 1.1 6.5 ± 3.4 0.04 
Leg LTM (kg) 20.0 ± 2.7 20.4 ± 2.8 1.8 ± 2.5 19.6 ± 2.6 20.0 ± 2.4 1.9 ± 2.7 0.02 
Trunk LTM (kg) 27.6 ± 5.0 27.9 ± 4.9 1.3 ± 3.1 25.9 ± 2.6 26.7 ± 2.9 2.9 ± 4.3 0.2 
Total FM (Arm+Leg+Trunk)  (kg) 19.7 ± 9.9 19.3 ± 9.4 -1.1 ± 7.7 21.0 ± 7.3 20.1 ± 5.6 -1.6 ± 15.6 0.02 
Total LTM (Arm+Leg+Trunk) (kg) 54.2 ± 7.9 55.2 ± 8.0 2.0 ± 2.1 52.0 ± 5.6 53.6 ± 5.9 2.9 ± 2.5 0.2 
Total STM 76.7 ± 16.7 77.4 ± 16.1 1.1 ± 2.2 75.8 ± 7.7 76.4 ± 6.6 1.0 ± 4.0 0.02 
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Table 3:  Average daily dietary intakes over a period of 4 days (2 training days, 1 weekend day and 1 non-training weekday) in the middle of the 
training period. Total energy Intake (TEI).  
 
Dietary Variables Placebo (n = 12) Leucine (n = 11) 
Carbohydrate intake (kcal) 1180.7 ± 344.9 1012.2 ± 210.6 
Protein intake (kcal) 393.7 ± 108.6 355.0 ± 67.2 
Fat intake (kcal) 853.5 ± 215.3 718.2 ± 165.7 
Alcohol intake (kcal)  96.6 ± 163.8 182.7 ± 290.2 
Carbohydrate (% of TEI) 48.2 ± 7.4 46.3 ± 7.5 
Protein (% of TEI) 16.0 ± 2.5 16.5 ± 3.5 
Fat (% of TEI) 34.8 ± 4.9 33.2 ± 8.0 
Alcohol (% of TEI) 4.0 ± 6.6 6.9 ± 10.1 
TEI (kcal) 2450.6 ± 554.0 2204.8 ± 444.8 
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RPE 
Ratings of perceived exertion (RPE) during each hypertrophy workout (session 
RPE) ranged from 16.2 (±1.9) to 17.6 (±1.2) and 16.1 (±1.9) to 17.8 (±1.3) for P 
and L groups respectively. During the strength workouts session RPE ranged from 
16.2 (±1.4) to 18.3 (±0.8) and 16.3 (±1.6) to 18.1 (±1.1) for P and L groups 
respectively. Significant differences did not exist between groups. There was 
neither a condition main effect (P = 0.499 for hypertrophy and P = 0.865 for 
strength workouts) nor an interaction main effect (P = 0.175 for hypertrophy and 
P = 0.540 for strength workouts).  
 
Seven day physical activity recall 
The physical activity recall data showed no differences in the number or intensity 
in work related and/or other activity levels between both groups. 
 
Blood 
All blood variables were within the normal range (as provided by the Department 
of Clinical Biochemistry and Immunology, Leeds General Infirmary). No 
significant differences between groups were found. 
 
Discussion 
The resistance training program for the novice weight trainers employed in the 
current study was associated with positive adaptations in strength and LTM for 
both the P and L groups. The magnitude of gains for both groups was in the 
expected range of approximately 20-40% for moderately trained and untrained 
individuals.14 Daily ingestion of leucine during 12 weeks of resistance training 
was accompanied by significantly greater gains in 5-RM strength in 5 out of 8 
resistance exercises and 5-RM total strength compared to similar training with a 
placebo. 
 
The gains observed in strength in both groups in the present study are most likely 
the result of the prescribed supervised resistance training program. Participants 
were clearly instructed to refrain from any lifestyle or activity modifications 
(other than the weight training sessions) during the experimental period. Hence, 
differences between the two conditions are likely to be attributed to the ingestion 
of leucine supplementation. The groups engaged in exactly the same type and 
volume of supervised resistance exercises and received the same training stimulus 
during these sessions as indexed by similar RPE ratings for both the hypertrophy 
and strength workouts. Also, participants did not differ in activity or exercise 
levels towards the end of the intervention program nor did they differ in their 
dietary intake. Of course, differences in genetics or muscle fibre distribution 
might result in inter-individual differences in progress. Because genotype has a 
bearing on the magnitude of gains in strength and/or FFM on its own right, 
recruitment of identical twins might be the best way to test the effectiveness of 
leucine as an ergogenic aid. However, the control mechanisms in place in the 
present study provide support for the notion that leucine supplementation might 
act as an ergogenic aid in novice weight trainers. 
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Our hypothesis that leucine supplementation would lead to greater gains in 
strength due to additional gains in muscle growth was supported by the strength 
data but only weakly supported by the LTM data (Table 2). The leucine group had 
slightly higher percentage gains and losses in total LTM and FM respectively than 
the P group but none of these differences were significant. However, the small 
effect size (Table 2) in trunk and total LTM suggests that a study with a longer 
duration and a higher training frequency may have resulted in significant 
differences between groups in LTM. The current study design was implemented 
to improve adherence to the study protocol. Despite the fact that participants were 
only required to engage in training twice per week only 26 out of 40 participants 
completed the required number of training sessions. This resulted in a drop-out of 
35%. An aim of future studies would be to improve adherence to training 
programs.  
 
The dietary intakes of the participants were under the estimated energy 
requirements but all within the 15% expected underestimation27 when food diaries 
are used. Ingestion of extra amino acids through the diet, which may have 
favoured one of the groups in terms of muscle protein synthesis, was not the case 
since the protein intake per kilogram of body weight was identical in both groups. 
Thus, the most likely explanation of the marginally higher gains in LTM of the L 
group, supported by a small effect size in LTM and accompanied by significantly 
greater gains in 5-RM strength, was leucine supplementation. We acknowledge 
that four days of diet records may not be adequate to estimate actual intakes 
across the twelve weeks. However, it has been shown that as dietary record 
duration increases, the accuracy and recording declines.28  
 
We can only speculate about the mechanisms of action since the data collected is 
not appropriate for this purpose. Co-ingestion of leucine and protein has shown to 
elicit a greater anabolic response in untrained individuals than carbohydrate alone 
or carbohydrate/protein,5 whilst removal of leucine in the presence of all other 
amino acids can decrease protein synthesis by 40%.29 Thus, it is probable that 
leucine supplementation further enhanced the rates of muscle protein synthesis in 
our L group when compared to diet alone and to some extent this is supported by 
the small effect size in LTM. Others have suggested that addition of leucine to a 
whey protein supplement before exercise does not result in greater anabolic 
responses than whey protein alone.6 However, this needs to be further investigated 
since neither a whey alone nor a leucine alone group were included in their study. 
The role of amino acids, obtained from either endogenous or exogenous sources, 
in enhancing the rate of protein synthesis cannot be ignored; as in some conditions 
leucine enhances protein synthesis only in the presence of these other amino 
acids.30 However, it is unlikely our participants were depleted of any amino acids 
since protein intake was adequate and similar in both groups and supplements 
were co-ingested with food during the non-exercising days. It is also unlikely the 
significant gains in 5-RM strength of L group was the result of amelioration of 
central fatigue since leucine ingestion elevates plasma leucine and BCAA 
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concentrations without affecting plasma free-tryptophan and the ratio of free-
tryptophan to BCAA ratio.7  
 
Although the dose used in the current study (4 gd-1) seems to be an adequate 
amount to effect positive adaptations during 12 weeks of combined resistance 
training and supplementation in novice weight trainers, different dosages of 
leucine (higher or lower) should also be tested in future studies. Older individuals 
seem to require higher doses of leucine for stimulation of protein synthesis.4 
However, more evidence-based research to test the efficacy and safety of different 
dosages is needed, before prescription of higher dosages. In our study, there was 
no evidence to suggest that 4 gd-1 leucine ingestion for a period of up to 12 weeks 
during resistance training negatively affected the health of the male participants as 
indicated by tests of liver function and full blood counts. 
 
Practical applications 
The additional strength gains in the L group support the use of leucine as a diet 
supplement to improve strength and ultimately performance in everyday life and 
athletic disciplines. In cases where supplementation is deemed necessary (e.g. 
high intensity, high volume exercise), supplementation could be considered and 
complement an appropriate diet. An investigation of special significance would be 
to test the hypothesis that leucine supplementation may be of benefit in diseases in 
which lean body mass is compromised by atrophy such as type II diabetes based 
on supporting evidence that leucine can attenuate body wasting.2  
 
Conclusion 
In conclusion, the resistance training program employed in the current study 
increased strength of initially untrained male participants regardless of whether 
they ingested leucine or a placebo. However, those participants ingesting leucine 
had the greatest increase in strength. The data therefore suggest that regular 
ingestion of leucine while undertaking a resistance training program may 
accentuate strength gains. However, given the small effect size in LTM, more 
research is needed before any concrete conclusions can be made regarding the 
efficacy of leucine as an ergogenic aid. 
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